These Stocks Are Setting Today’s Tone

October 9, 2025

DENVER, Colo., Oct 09, 2025 (247marketnews.com)- Today’s session is dominated by a surge in strategic partnerships, public market debuts, and industry-disrupting business models driving investor focus. Here’s what you need to know:

Bluejay Diagnostics (NASDAQ:BJDX) is in focus after announcing a major expansion of its strategic partnership with Japan’s SanyoSeiko, a move that formally names the precision-engineering firm as Bluejay’s full-service contract manufacturing organization for the Symphony platform. This near-patient diagnostic system is designed to rapidly detect biomarkers such as IL-6, critical in sepsis management, a massive global healthcare challenge.

Under the new agreement, SanyoSeiko will now provide end-to-end support: from hardware/software redevelopment and raw material sourcing to packaging, quality control, and regulatory support. CEO Neil Dey called the move a “key milestone” that enhances “supply chain resilience” and accelerates Symphony’s readiness for clinical deployment. As BJDX edges closer to commercialization, this expanded deal could validate the company’s go-to-market strategy and reignite investor interest.

VENU (NYSE:VENU) continues its ascent after revealing that demand for its Luxe FireSuites surpassed $23 million in just two months, $10.7M in August, $12.3M in September, marking an all-time high for the company’s flagship sports hospitality product. The “fan-first real estate” model, which blends experiential ownership with long-term revenue streams, is clearly gaining traction.

VENU also announced that its highly anticipated fine dining concept, Roth’s Sea & Steak, will officially open on November 8, 2025, in Colorado Springs. Perched above the Pollstar-nominated Ford Amphitheater, the restaurant offers panoramic views of the Colorado Front Range and the stage below, blending world-class scenery with Michelin-caliber cuisine. The expanded culinary team now includes Sushi Chef Dillon Tafoya, whose expertise complements a menu rooted in Colorado’s finest seasonal ingredients, paired with a curated cocktail program and exclusive wine series. Reservations are now open at www.rothsseaandsteak.com.

Adding fuel to the rally: bullish analyst coverage from Cenorium Capital (Strong Buy, $22 PT), ThinkEquity (Buy, $18), and Northland Securities (raised from $15 to $17). Institutional conviction is building, with a recent $34 million raise completed around $12 per share, offering a solid valuation floor. With expansion plans underway in Dallas, El Paso, and Tulsa, VENU is fast becoming a story stock with both real-world demand and speculative momentum.

Turn Therapeutics (NASDAQ:TTRX) officially began trading yesterday, marking its Nasdaq debut with a ceremonial bell-ringing by CEO Bradley Burnam. The clinical-stage biotech develops next-generation wound care and dermatology therapies, positioning itself at the intersection of infectious disease management and advanced materials science.

With its S-1 declared effective by the SEC just last week, TTRX enters the public markets amid renewed investor interest in innovative anti-infective platforms. Traders will be watching closely to see how the stock stabilizes post-IPO, especially as pipeline updates and institutional coverage begin to materialize in the weeks ahead.

In one of the morning’s most high-profile deals, Serve Robotics (NASDAQ:SERV) and DoorDash (NASDAQ:DASH) announced a multi-year partnership to deploy autonomous sidewalk delivery robots across the U.S., starting with Los Angeles. This initiative extends Serve’s already proven track record, over 100,000 deliveries completed from 2,500+ restaurants, to a national scale through DoorDash’s massive logistics platform.

DoorDash says the integration of Serve aligns with its “multi-modal” strategy, which blends Dashers, drones, and autonomous robots to improve efficiency and sustainability. SERV CEO Dr. Ali Kashani called the partnership a leap toward “making robotic delivery available in every neighborhood,” which could mark a true inflection point in how last-mile delivery is commercialized.

For DASH, this adds another layer of automation to its dominant logistics stack. For SERV, it provides scale, recurring revenue potential, and the spotlight it needs to attract new investors.

Shares of Critical Metals Corp (NASDAQ:CRML) are rallying sharply after a Reuters report that the U.S. government is considering taking an equity stake in the company’s Greenland rare earth project, possibly converting a $50 million grant into an 8 % stake.
That story dovetails with CRML’s recent strategic moves: the company has amended its agreement with Rimbal Pty Ltd to raise its ownership in the Tanbreez project from 42 % to 92.5 %, via issuance of ~14.5 million shares.

USA Rare Earth (NASDAQ:USAR) has quietly transformed from a pure play in mining into a vertically integrated rare earth + magnet strategy.
Today’s focus:

  • The company recently agreed to acquire Less Common Metals (LCM), a U.K. rare earth metal/alloy producer, via $100 million cash + 6.74 million USAR shares. That acquisition fills a crucial midstream gap.
  • Concurrently, USAR closed a $125 million PIPE at $15.00 per share to help fund that deal and its magnet plant expansion.
  • Operationally, USAR has commissioned an Innovations Lab in Stillwater, OK to prototype neo magnets ahead of full production in early 2026.
  • On the financial front, USAR ended Q2 2025 with ~$121.8 million in cash and no significant debt, though it also warned of “going concern” risk.

The rhetoric around USAR is now about sovereignty: being one of the few companies globally with “mine-to-magnet” capability outside China.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, including analyst reports, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC (247) Disclaimer and Disclosure
PAID EDITORIAL DISCLOSURE: 247MarketNews.com has been compensated $2,500 per week by MicroCap Strategies for ongoing press and editorial coverage of VENU. This is a paid editorial communication intended for informational purposes only. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please go to https://247marketnews.com/venu-disclosure/ for additional 247marketnews.com VENU disclosure information.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (VENU, BJDX, TTRX, SERV, DASH, CRML)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.